KRAS and rectal neoplasm: Mutational analysis of rectal tumor organoids confirmed that they harbored patterns of genetic alterations that are typical of sporadic CRC, with mutations in APC (6/6), TP53 (4/6), and KRAS (3/6) (Figure 2a).